| Identification | Back Directory | [Name]
3-Pyridinecarboxamide, 5-bromo-6-chloro-N-[4-(chlorodifluoromethoxy)phenyl]- | [CAS]
1491150-22-1 | [Synonyms]
3-Pyridinecarboxamide, 5-bromo-6-chloro-N-[4-(chlorodifluoromethoxy)phenyl]- | [Molecular Formula]
C13H7BrCl2F2N2O2 | [MOL File]
1491150-22-1.mol | [Molecular Weight]
412.01 |
| Hazard Information | Back Directory | [Uses]
5-Bromo-6-chloro-n-(4-(chlorodifluoromethoxy)phenyl)nicotinamide is a pharmaceutical intermediate compound used in the preparation of the anti-tumour drug Asciminib. Asciminib is a tyrosine kinase inhibitor (TKI) indicated for the treatment of chronic phase Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML). |
|
|